Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference45 articles.
1. International Agency for Research on Cancer, World Health Organisation. Globocan 2018: United Kingdom Factsheet. 2018.
http://gco.iarc.fr/today/data/factsheets/populations/826-united-kingdom-fact-sheets.pdf
. Accessed 5 Dec 2018.
2. Cancer Research UK. Cancer in the UK 2018. 2018.
https://www.cancerresearchuk.org/sites/default/files/state_of_the_nation_apr_2018_v2_0.pdf
. Accessed 22 Aug 2018.
3. Oke JL, O’Sullivan JW, Perera R, Nicholson BD. The mapping of cancer incidence and mortality trends in the UK from 1980–2013 reveals a potential for overdiagnosis. Sci Rep. 2018;8(1):14663.
4. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–38.
5. Davis C, Naci H, Gurpinar E, Poplavska E, Pinto A, Aggarwal A. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009–13. BMJ. 2017;359.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献